Chapter 35. Prevention

  1. Howard Thomas BSc PhD FRCP FRCpath FMedSci Professor1,
  2. Stanley Lemon Professor2 and
  3. Arie Zuckerman MD, DSc, FRCP, FRCPath, FMedSci, Dip. Bact Professor3
  1. Sergio Abrignani,
  2. Grazia Galli and
  3. Michael Houghton

Published Online: 26 OCT 2007

DOI: 10.1002/9780470987131.ch35

Viral Hepatitis, Third Edition

Viral Hepatitis, Third Edition

How to Cite

Abrignani, S., Galli, G. and Houghton, M. (2005) Prevention, in Viral Hepatitis, Third Edition (eds H. Thomas, S. Lemon and A. Zuckerman), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987131.ch35

Editor Information

  1. 1

    Dean (Clinical) Faculty of Medicine, Imperial College, Department of Medicine, Queen Elizabeth Queen Mother Wing, St Mary's Hospital Medical School, London UK

  2. 2

    Dean of Medicine, Department of Microbiology & Immunology & Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

  3. 3

    The Royal Free Hospital of Medicine, Rowland Hill Street, London, UK

Publication History

  1. Published Online: 26 OCT 2007
  2. Published Print: 12 JUL 2005

ISBN Information

Print ISBN: 9781405130059

Online ISBN: 9780470987131



  • hepatitis C prevention;
  • hepatitis C virus (HCV) vaccine;
  • cell-mediated responses;
  • antibody response;
  • HCV proteins


This chapter contains sections titled:

  • Introduction

  • What should an HCV vaccine protect against?

  • How difficult will it be to develop an HCV vaccine?

  • Virology of the hepatitis C virus

  • Immune correlates of protection

  • Role of cell-mediated responses

  • Role of the antibody response

  • Strategies for an HCV vaccine

  • Conclusions